This past Friday, FDA commissioner Scott Gottlieb revealed a series of new regulations targeting both traditional cigarettes and vaping products. These rules, set to roll out in the coming months or years, include a groundbreaking measure: the removal of the addictive substance in cigarettes.
Nicotine is the primary reason smokers find it hard to quit; Gottlieb describes it as “incredibly addictive.” However, it’s the other harmful substances in cigarettes, along with the toxic smoke produced when burned, that lead to serious health issues like cancer, heart disease, and lung conditions. By eliminating or significantly reducing nicotine to non-addictive levels, the FDA hopes to drastically decrease smoking rates and its associated health risks.
Gottlieb explained it this way:
Exploring methods to lower nicotine levels in cigarettes to make them minimally or non-addictive, while maintaining the nicotine content in noncombustible products like e-cigarettes, is a key part of our updated and more comprehensive strategy for effective tobacco regulation. Congress has explicitly granted the FDA this authority.
If this regulation is successfully implemented—despite facing significant bureaucratic hurdles and resistance from the industry—we might see a future where cigarettes retain tar but are stripped of nicotine. On the other hand, vaping products would continue to contain nicotine without the harmful tar, a balance the FDA appears determined to maintain.
